🎁 Black Friday: up to 50% off of annual plans
Azora Therapeutics, Inc. (AZR)
NASDAQ: AZR · Real-Time Price · USD
3.850
-0.020 (-0.52%)
At close: Nov 20, 2026, 4:00 PM EST
3.770
-0.080 (-2.08%)
After-hours: Nov 20, 2026, 6:33 PM EST

Azora Therapeutics Stock Forecast

Stock Price Forecast

According to 4 analysts polled by S&P Global, Azora Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $10.67. The average 1-year stock price forecast is 177.14% higher than the current stock price, while the lowest is $6.00 (+55.84%) and the highest is $14 (+263.64%).

Price Target: $10.67 (+177.14%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$6.00$10.67$12$14
Change+55.84%+177.14%+211.69%+263.64%

Analyst Ratings

The average analyst rating for Azora Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingNov '26
Strong Buy3
Buy1
Hold0
Sell0
Strong Sell0
Total4

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
JonesTrading
JonesTrading
Buy
Maintains
$14
BuyMaintains$14+263.64%Nov 20, 2026
Maxim Group
Maxim Group
Buy
Maintains
$12
BuyMaintains$12+211.69%Nov 17, 2026
TD Cowen
TD Cowen
Buy
Maintains
n/a
BuyMaintainsn/an/aNov 2, 2026
Alliance Global Partners
Alliance Global Partners
Buy
Initiates
$11
BuyInitiates$11+185.71%Aug 3, 2026
Lucid Capital
Lucid Capital
Buy
Initiates
$6
BuyInitiates$6+55.84%Jun 15, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
n/a
EPS Next Year
-14.42
Fiscal YearFY 2025E
Period EndingDec 31, 2025

Revenue Forecast

Revenue202520262027
Highn/a
Avgn/a
Lown/a

Revenue Growth

Revenue Growth20262027
High-
Avg-
Low-

EPS Forecast

EPS202520262027
High-
Avg-
Low-

EPS Growth

EPS Growth20262027
High-
Avg-
Low-